A generic beginning with A has which FDA classification?

• A. Has potential bioequivalence problems and MAY not produce the same therapeutic effect
• B. Has been given an 'equivalent' classification by the FDA
• C. Has an unknown status
• D. Has been declared unsafe for use

Answer: (B)

The idea being tested is how the FDA signals that a generic product can be used interchangeably with a brand-name product. If a generic is given an equivalent classification by the FDA, that means it has demonstrated bioequivalence to the reference product in appropriate studies, so it should produce the same therapeutic effect and safety profile. Because of that, it is considered interchangeable with the brand-name drug, which is why this option is the best fit.

In contrast, saying the generic has potential bioequivalence problems would imply it’s not equivalent, which contradicts the meaning of an equivalent classification. An unknown status or being declared unsafe would also not apply to an FDA-approved generic that carries an equivalent rating.